home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

How And When Should Genetic Tests For Cancer Be Used?

  June, 7 2006 12:29
your information resource in human molecular genetics
There are many genetic tests that provide information about cancer risk - but how are ethical judgements made about who should be offered them? When do the benefits of knowing that you are at increased risk of a hereditary cancer outweigh the harmful anxiety it causes, and who decides how the patient's health should then be managed?

In an article published online by Nature Reviews Cancer (Vol. 6, No. 6) two experts in the use of genetic testing call for primary-care physicians and oncologists to work with medical geneticists and genetic counsellors, to identify the best clinical course of action.

Such a framework will help clinicians to recognise potential genetic risk and identify people for testing while also weighing this information against the potential risks of overdiagnosis, overtreatment, or of identifying a mutation of unknown significance. Consensus-based guidelines are already being developed to help clinicians decide when a genetic test has sufficient potential benefit to be used. Indeed, in the UK, the National Institute for Health and Clinical Excellence is putting some of these guidelines into practice.

Author contact
Wylie Burke (University of Washington, Seattle, WA, USA)
E-mail: wburke@u.washington.edu

Editorial contact
Ezzie Hutchinson (Chief Editor, Nature Reviews Cancer)
E-mail: e.hutchinson@nature.com

Abstract available online.

(C) Nature Reviews Cancer press release.

Posted by: Tressie Dalaya

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.